AIkido Pharma Inc. (AIKI): Price and Financial Metrics


AIkido Pharma Inc. (AIKI): $3.56

0.01 (+0.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AIKI to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

AIKI Stock Price Chart Interactive Chart >

Price chart for AIKI

AIKI Price/Volume Stats

Current price $3.56 52-week high $11.48
Prev. close $3.55 52-week low $3.31
Day low $3.50 Volume 31,900
Day high $3.67 Avg. volume 79,326
50-day MA $4.72 Dividend yield N/A
200-day MA $5.81 Market Cap 19.53M

AIkido Pharma Inc. (AIKI) Company Bio


Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.


AIKI Latest News Stream


Event/Time News Detail
Loading, please wait...

AIKI Latest Social Stream


Loading social stream, please wait...

View Full AIKI Social Stream

Latest AIKI News From Around the Web

Below are the latest news stories about AIKIDO PHARMA INC that investors may wish to consider to help them evaluate AIKI as an investment opportunity.

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today provided an update on the $2 million share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on December 5, 2022.

Yahoo | December 28, 2022

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AIkido Pharma Inc. to Dominari Holdings Inc. and its ticker symbol from "AIKI" to "DOMH." The Company expects that its shares of common stock will begin trading on The Nasdaq Stock Market under the new name and new stock ticker symbol "DOMH" on or about December 22, 2022.

Yahoo | December 22, 2022

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes ("ASPI"). ASPI priced its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $5.0 million before deducting underwriting discounts, commissions, and other offering expenses.

Yahoo | November 28, 2022

AIkido Pharma (AIKI) Gets a Buy from H.C. Wainwright

In a report released today, Vernon Bernardino from H.C. Wainwright maintained a Buy rating on AIkido Pharma (AIKI - Research Report), with a price target of $16.00. The company's shares opened today at $4.30.Bernardino covers the Healthcare sector, focusing on stocks such as Geron, Artelo Biosciences, and Cassava Sciences. According to TipRanks, Bernardino has an average return of 19.4% and a 32.49% success rate on recommended stocks. AIkido Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $16.00.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $13.90 and a one-year low of $4.14.

Ryan Adist on TipRanks | November 11, 2022

AIkido Share Repurchase Continues

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on January 21, 2022.

Yahoo | October 6, 2022

Read More 'AIKI' Stories Here

AIKI Price Returns

1-mo N/A
3-mo -35.27%
6-mo -39.35%
1-year -57.03%
3-year -79.47%
5-year -96.30%
YTD N/A
2022 0.00%
2021 -32.80%
2020 -33.83%
2019 -51.47%
2018 -54.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6104 seconds.